Premchand Godha's strategy for IPCA has not changed, it's about being integrated and focusSING on profitability

DeepMind CEO Demis Hassabis says the company's AlphaFold has been validated as a solution to the 'protein folding problem' and it hopes it will have a big impact on disease understanding and drug discovery

In stark contrast to the mayhem around the world, India's top three candidates - Serum-Oxford, Bharat Biotech and Zydus Cadila continued their scientific pursuits unobtrusively (the fourth, DRL-Gamaleya, just started India trials). At least 16 more vaccines are under development at home

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

Since the pandemic, India has created a robust regulatory and collaborative ecosystem and partnerships between various stakeholders under the National Biopharma Mission (NBM) to speed up vaccine development

Stocks to watch today on November 20: RIL, Gland Pharma, SBI, Alkem Labs, Bharti Infratel, Wipro, Infosys among others are the top stocks to watch out for in Friday's trading session

Researchers made their discovery while developing highly sensitive antibody tests for COVID-19. They compared the blood of COVID-19 patients with that of patients who had not had the disease

India Stock Market Highlights Today: IndusInd Bank, followed by HDFC, Tata Steel, ICICI Bank, Axis Bank, SBI, Titan, Kotak Bank and Reliance Industries were among the top gainers today. On the other hand, Nestle India, HUL and TCS were among the laggards

Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing

\"It (candidate drug PNB-001) has shown remarkable results in lung inflammation and ARDS (Acute Respiratory Distress Syndrome)\", says PN Balaram, CEO of PNB Vesper

Speaking at the 14th Annual BioPharma and Healthcare Summit, he said India is now gearing up for innovation in its pharmaceutical ecosystem focusing on speedy and scaled up delivery of new vaccines and personalised medicines

To tide over the COVID-19 pandemic led crisis, the company in the near-term is deferring its major capex plans, without sacrificing growth, until the business environment stabilises

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF)

The drug discovery pipeline is a type of computational strategy linked to AI -- a computer algorithm that learns to predict activity through trial and error, improving over time

The company has successfully completed the Phase-I and Phase II studies. Phase-III clinical study is expected to be initiated by December 2020.

Eventually everything rests on the Future of the Economy. Former RBI Deputy Governor Viral Acharya reminds us that an inter-dependent, inter-connected world is vital to the growth of the global economy

Top Indian and global CEOs and experts on why the future is bright

Mining of huge data will enhance the probability of finding new drugs, making India the laboratory of the world

The trials showed that the average time coronavirus patients spent in hospital was reduced by a third, for those receiving the new drug - down from an average of nine days to six days

Coronavirus vaccine news update: Bill Gates said in a documentary that India has a lot of capacity and that the Indian pharma industry is doing a lot of important things